Welcome to the newsroom archive
of AOP Health
Please find below archived press releases
Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via firstname.lastname@example.org
Austria as a Research & Development base
31. 8. 2017
AOP in Press: "New Therapies To Struggle Against Established Hematology"
11. 7. 2017
AOP and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera
23. 6. 2017
AOP Orphan Pharmaceuticals AG and Amomed Pharma GmbH announce the launch of RAPIBLOC® (Landiolol) in Germany and Austria.
19. 6. 2017
Rare Diseases: AOP Orphan Pharmaceuticals AG invests in sustainable Research & Development
16. 5. 2017
Miroslaw Jan Lubecki – newly appointed Chief of Commercial Operations
12. 4. 2017